10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (60%) |
| §102 only | 2 (20%) |
| §112 only | 1 (10%) |
| No statute on record | 1 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, MIKHAIL O'DONNEL | 1 | 57.5% | +42.7% |
| PYLA, EVELYN Y | 1 | 55.6% | +47.4% |
| BUNNER, BRIDGET E | 1 | 64.2% | +19.8% |
| HUMPHRIES, NICHOLAS ADAM | 1 | 35.5% | +78.1% |
| BAUSCH, SARAE L | 1 | 29.6% | +44.2% |
| TURK, NEIL N | 1 | 50.9% | +44.4% |
| PERSONS, JENNA L | 1 | 51.7% | +58.4% |
| CHO, DAVID H | 1 | 38.5% | +72.7% |
| POLIAKOVA-GEORGAN, EKATERINA | 1 | 64.3% | +17.6% |
| JONES, LOGAN P | 1 | 42.9% | +32.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17997572 | Epiprinter Technology and Methods of Use for Detecting Biomolecules | BAUSCH, SARAE L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17938209 | BAG3 AS A TARGET FOR THERAPY OF HEART FAILURE | POLIAKOVA-GEORGAN, EKATERINA | 84d overdue |
| 18609070 | Use of Short Chain Fatty Acids in Cancer Prevention | PYLA, EVELYN Y | 2d overdue |
| 17945222 | GAS BURNER ATTACHMENT | JONES, LOGAN P | 19d |
| 18300468 | PHARMACOLOGIC APPROACH FOR SUPPRESSION OF CORONAVIRUSES | CHO, DAVID H | 63d |
| 17817696 | METHOD OF DIAGNOSIS, PROGNOSIS, AND TREATMENT OF VITAMIN D DEFICIENCY AND VITAMIN D IMBALANCE AND DISEASES AND DISORDERS ASSOCIATED THEREOF | TURK, NEIL N | 69d |
| 18793238 | METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASE | ROBINSON, MIKHAIL O'DONNEL | — |
| 18515636 | MonoMac-1 Cells Expressing CD16 and CD163 | BUNNER, BRIDGET E | — |
| 18549948 | Noninvasive AAV Vectors For Highly Efficient Gene Delivery To The Nervous System | HUMPHRIES, NICHOLAS ADAM | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1647 | 1 |
| 1631 | 1 |
| 1699 | 1 |
| 1798 | 1 |
| 1693 | 1 |
| 1637 | 1 |
| 3762 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18793238 | METHODS AND COMPOSITIONS FOR TREATING LIVER DISEASE | ROBINSON, MIKHAIL O'DONNEL | — | §103 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18609070 | Use of Short Chain Fatty Acids in Cancer Prevention | PYLA, EVELYN Y | 1633 | §103 | Non-Final OA | 2d overdue | Pending | Mar 19, 2024 |
| 18515636 | MonoMac-1 Cells Expressing CD16 and CD163 | BUNNER, BRIDGET E | 1647 | §102 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18549948 | Noninvasive AAV Vectors For Highly Efficient Gene Delivery To The Nervous System | HUMPHRIES, NICHOLAS ADAM | 1631 | §103 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 17997572 | Epiprinter Technology and Methods of Use for Detecting Biomolecules | BAUSCH, SARAE L | 1699 | §103 | Final Rejection | — | Pending | Oct 31, 2022 |
| 17817696 | METHOD OF DIAGNOSIS, PROGNOSIS, AND TREATMENT OF VITAMIN D DEFICIENCY AND VITAMIN D IMBALANCE AND DISEASES AND DISORDERS ASSOCIATED THEREOF | TURK, NEIL N | 1798 | §112 | Final Rejection | 69d | Pending | Aug 05, 2022 |
| 18577107 | OLIGONUCLEOTIDES AND VIRAL UNTRANSLATED REGION (UTR) FOR INCREASING EXPRESSION OF TARGET GENES AND PROTEINS | PERSONS, JENNA L | — | §102 | Non-Final OA | — | Pending | Jan 05, 2024 |
| 18300468 | PHARMACOLOGIC APPROACH FOR SUPPRESSION OF CORONAVIRUSES | CHO, DAVID H | 1693 | §103 | Final Rejection | 63d | Pending | Apr 14, 2023 |
| 17938209 | BAG3 AS A TARGET FOR THERAPY OF HEART FAILURE | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Other | Final Rejection | 84d overdue | Pending | Oct 05, 2022 |
| 17945222 | GAS BURNER ATTACHMENT | JONES, LOGAN P | 3762 | §103 | Non-Final OA | 19d | Pending | Sep 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial